These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19125134)

  • 1. Neurogenic bladder in a patient with systemic lupus erythematosus and cerebral involvement.
    Kim HA; Ye YM; Choi JB; Park HS; Suh CH
    J Clin Rheumatol; 2009 Feb; 15(1):40-1. PubMed ID: 19125134
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of systemic lupus erythematosus (SLE) with a neurogenic bladder, successful treatment with intravenous cyclophosphamide pulse therapy].
    Nakagawa M; Nishinarita M
    Ryumachi; 1999 Oct; 39(5):763-7. PubMed ID: 10614171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug alternatives in therapy of neuropsychiatric systemic lupus erythematosus (NPSLE)].
    Harten P
    Med Klin (Munich); 2003 Jun; 98(6):344; author reply 344-5. PubMed ID: 12877108
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous cyclophosphamide and high dose corticosteroids improve MRI lesions in demyelinating syndrome in systemic lupus erythematosus.
    Leung FK; Fortin PR
    J Rheumatol; 2003 Aug; 30(8):1871-3. PubMed ID: 12913950
    [No Abstract]   [Full Text] [Related]  

  • 5. Transient panhypogammaglobulinaemia and B-lymphocyte deficiency in a patient with neuropsychiatric systemic lupus erythematosus after immunosuppressive therapy.
    Song J; Park YB; Suh CH; Lee SK
    Clin Rheumatol; 2003 Feb; 22(1):62-6. PubMed ID: 12605322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral haemorrhage in a patient with systemic lupus erythematosus and vasculitis treated with intravenous immunoglobulins for a long-time and in absence of other risk factors.
    Giannitti C; Cerase A; Miracco C; Fioravanti A
    Clin Ter; 2011; 162(2):125-7. PubMed ID: 21533318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal corticosteroids for systemic lupus erythematosus with central nervous system involvement.
    Funauchi M; Ohno M; Nozaki Y; Sugiyama M; Kinoshita K; Kanamaru A
    J Rheumatol; 2003 Jan; 30(1):207-8. PubMed ID: 12508419
    [No Abstract]   [Full Text] [Related]  

  • 8. Fulminant onset of cerebral immunocomplex vasculitis as first manifestation of neuropsychiatric systemic lupus erythematosus (NPSLE).
    Rizos T; Siegelin M; Hähnel S; Storch-Hagenlocher B; Hug A
    Lupus; 2009 Apr; 18(4):361-3. PubMed ID: 19276305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic lupus erythematosus].
    Hirohata S
    Nihon Rinsho; 2004 Jan; 62 Suppl():429-34. PubMed ID: 15011400
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective involvement of the choroid plexus on cerebral magnetic resonance images: a new radiological sign in patients with systemic lupus erythematosus with neurological symptoms.
    Duprez T; Nzeusseu A; Peeters A; Houssiau FA
    J Rheumatol; 2001 Feb; 28(2):387-91. PubMed ID: 11246685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of cerebral large vessel vasculitis in systemic lupus erythematosus with intravenous pulse cyclophosphamide.
    Kato R; Sumitomo S; Kawahata K; Fujio K; Yamamoto K
    Lupus; 2015 Jul; 24(8):880-4. PubMed ID: 25661835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurological disorders in systemic lupus erythematosus patients].
    Hawro T; Bogucki A; Sysa-Jedrzejowska A; Bogaczewicz J; Woźniacka A
    Pol Merkur Lekarski; 2009 Jan; 26(151):43-8. PubMed ID: 19391506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premature atherosclerosis-related central nervous system involvement in two cases of systemic lupus erythematosus.
    Zhang X; Tian X; Zhang F
    J Clin Rheumatol; 2007 Aug; 13(4):211-2. PubMed ID: 17762456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of ocular involvement in systemic lupus erythematosus in a tertiary eye care center in Nepal.
    Sitaula R; Shah DN; Singh D
    Ocul Immunol Inflamm; 2011 Dec; 19(6):422-5. PubMed ID: 22106910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerosis and central nervous system involvement in systemic lupus erythematosus.
    Von Feldt JM
    J Clin Rheumatol; 2007 Aug; 13(4):179-80. PubMed ID: 17762449
    [No Abstract]   [Full Text] [Related]  

  • 16. Intestinal obstruction as the initial presentation of lupus mesenteric vasculitis.
    Li R; Chen Z
    J Clin Rheumatol; 2012 Sep; 18(6):319-20. PubMed ID: 22955485
    [No Abstract]   [Full Text] [Related]  

  • 17. [Transverse myelitis associated with systemic lupus erythematosus].
    Bataller-Peñafiel E; Alcobendas-Maestro M; Flores-Torres I; Esclarín-De Ruz A
    Rev Neurol; 2007 Nov 1-15; 45(9):573-5. PubMed ID: 17979090
    [No Abstract]   [Full Text] [Related]  

  • 18. Reversible basal ganglia and amygdala lesions in central nervous system lupus.
    Bhagavati S; Choi J
    J Rheumatol; 2008 Dec; 35(12):2451-3. PubMed ID: 19040321
    [No Abstract]   [Full Text] [Related]  

  • 19. Mannitol treatment in central nervous system lupus.
    Eren M; Baskin E; Cila A; Ozen S
    Clin Rheumatol; 2001; 20(2):160-1. PubMed ID: 11346235
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute pan-dysautonomia as well as central nervous system involvement and peripheral neuropathies in a patient with systemic lupus erythematosus.
    Yukawa S; Tahara K; Shoji A; Hayashi H; Tsuboi N
    Mod Rheumatol; 2008; 18(5):516-21. PubMed ID: 18551352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.